格隆汇11月26日丨泰坦科技(688133.SH)公布，基于公司整体发展战略及业务需要的考虑，公司和关联 方一期基金拟共同投资，对微源检测进行增资。增资前，微源检测注册资本为1000万元，泰坦科技 100%持股；增资后，微源检测注册资本为5000万元，其中泰坦科技持股70%，一期基金持股30%。微源 检测新增的4000万元注册资本，泰坦科技认缴2500万元，一期基金认缴1500万元，泰坦科技资金来源为 自有资金。 微源检测成立于2025年2月，公司聚焦实验室服务三大核心板块：验证与检测服务、分析检测仪器设备 租赁及售后、分析检测设备关键零部件研发制造，公司旨在成为国内领先的独立生化实验室一站式综合 服务平台。微源检测目前尚未开展业务，运营初期依托泰坦科技的平台，由泰坦科技负责提供初始的技 术管理团队、行业资源、部分场地设备等支撑。未来随着业务的扩展，微源检测将形成独立的运营团 队、技术团队、ERP系统等，作为泰坦科技控股子公司独立经营发展。 ...

评级调低方面，11月17日至11月23日，券商调低上市公司评级达到7家次，最新数据包括了华创证券对太阳能的评 级从"强推"调低至"推荐"，西部证券对源杰科技的评级从"买入"调低至"增持"，华创证券对泰坦科技的评级从"强 推"调低至"推荐"。 | | | | 7家最新被调低评级的公司 | | | | --- | --- | --- | --- | --- | --- | | 证券代码 | 证券名称 | 机构 | 此前评级 | 最新评级 | 行业 | | 000591 | 太阳能 | 华创证券 | 强推 | 推荐 | 电力 | | 688498 | 源杰科技 | 西部证券 | 采入 | 増持 | 半导体 | | 688133 | 泰坦科技 | 华创证券 | 强推 | 推荐 | 化学制品 | | 000938 | 紫光股份 | 西部证券 | 买人 | 増持 | IT服务 | | 688232 | 新点软件 | 中泰证券 | 买人 | 増持 | 软件开发 | | 688056 | 菜伯泰科 | 华创证券 | 賀推 | 推荐 | 通用设备 | | 002541 | 鸿路钢构 | 华创证券 | 賀推 | 推荐 | 专业工 ...

Group 1 - The core viewpoint of the articles highlights significant changes in stock ratings and target prices for various companies, with notable increases for Wan Feng Ao Wei, Guang Xun Technology, and Tai Chen Guang [1] - Wan Feng Ao Wei's target price increased by 89.64%, Guang Xun Technology by 81.99%, and Tai Chen Guang by 71.51%, all within the automotive parts and communication equipment sectors [1] - A total of 408 companies received broker recommendations during the period, with Yili receiving 5 recommendations, and Top Group and United Imaging Medical receiving 4 each [1] Group 2 - Three companies had their ratings upgraded, including Huadong Heavy Machine from "Hold" to "Buy" by Caixin Securities, Sinopec from "Add" to "Buy" by Huatai Securities, and Hongyuan Electronics from "Add" to "Buy" by CITIC Securities [1] - Seven companies had their ratings downgraded, including Solar Energy from "Strong Buy" to "Recommended" by Huachuang Securities, Source Technology from "Buy" to "Add" by Western Securities, and Titan Technology from "Strong Buy" to "Recommended" by Huachuang Securities [1] - During the same period, 77 instances of first-time coverage were reported, with Delijia receiving an "Outperform" rating from Guosen Securities, and YTO Express, Yanjiang Co., and Far East Co. receiving "Add" or "Buy" ratings from various brokers [2]

Investment Rating - The report has downgraded the investment rating to "Recommendation" with a target price of 25.6 CNY, indicating a potential upside of 16% from the current price of 22.15 CNY [2][8]. Core Views - The company is experiencing revenue and profit pressure in Q3 2025, with a year-on-year revenue decline of 13.75% and a significant drop in net profit by 69.57% in the same quarter [2][8]. - Despite short-term performance challenges, the long-term outlook for the scientific services industry remains positive, with expectations of a recovery in downstream demand leading to a performance inflection point [8]. - The company is actively restructuring its business to focus on higher-margin operations, which has resulted in a slight improvement in gross margin to 22.15% [8]. Financial Summary - For the first three quarters of 2025, the company reported a total revenue of 1.848 billion CNY, down 13.06% year-on-year, while net profit attributable to shareholders was 11 million CNY, up 15.04% year-on-year [2][8]. - The projected revenues for 2025 to 2027 are 2.634 billion CNY, 2.812 billion CNY, and 3.072 billion CNY, respectively, with expected growth rates of -8.6%, 6.7%, and 9.2% [4][9]. - The net profit forecast for the same period is 16 million CNY, 36 million CNY, and 59 million CNY, with growth rates of 23.8%, 125.7%, and 64.4% respectively [4][9]. - The company has a current market capitalization of 3.642 billion CNY and a debt-to-equity ratio of 55.3% [5][9].

Company Overview - Titan Technology Co., Ltd. is located at 89 Shilong Road, Xuhui District, Shanghai, established on October 18, 2007, and listed on October 30, 2020 [1] - The company provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, smart laboratory equipment, research information technology, specialty chemicals, and related comprehensive technical services [1] - The revenue composition of Titan Technology is as follows: research reagents 42.70%, research instruments and consumables 28.42%, specialty chemicals 26.48%, laboratory construction and research information technology 2.37%, and others 0.02% [1] Financial Performance - As of September 30, Titan Technology reported a total revenue of 1.848 billion yuan for the period from January to September 2025, a year-on-year decrease of 13.06% [2] - The net profit attributable to the parent company was 11.1678 million yuan, reflecting a year-on-year increase of 15.04% [2] - Cumulative cash dividends since the A-share listing amount to 86.6205 million yuan, with 40.1089 million yuan distributed over the past three years [3] Stock Performance - On November 20, Titan Technology's stock price decreased by 2.01%, trading at 22.92 yuan per share, with a total market capitalization of 3.769 billion yuan [1] - The stock has seen a year-to-date increase of 26.14%, but has declined by 7.99% over the last five trading days, 8.14% over the last 20 days, and 18.26% over the last 60 days [1] - As of the latest data, the number of shareholders is 9,293, an increase of 20.41% from the previous period, while the average circulating shares per person decreased by 16.95% to 17,694 shares [2] Market Activity - The net outflow of main funds was 4.5418 million yuan, with large orders buying 4.3981 million yuan (16.17% of total) and selling 8.9399 million yuan (32.87% of total) [1] - Titan Technology is categorized under the basic chemicals industry, specifically in the chemical products sector, and is associated with concepts such as buybacks, margin financing, pension concepts, scientific instruments, and electronic chemicals [1]

Company Overview - Titan Technology Co., Ltd. is located at 89 Shilong Road, Xuhui District, Shanghai, established on October 18, 2007, and listed on October 30, 2020 [1] - The company provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, smart laboratory equipment, research information technology, specialty chemicals, and related comprehensive technical services [1] Financial Performance - For the period from January to September 2025, Titan Technology achieved operating revenue of 1.848 billion yuan, a year-on-year decrease of 13.06% [2] - The net profit attributable to the parent company was 11.1678 million yuan, representing a year-on-year increase of 15.04% [2] - Cumulative cash dividends since the A-share listing amount to 86.6205 million yuan, with 40.1089 million yuan distributed over the past three years [3] Stock Performance - As of November 12, Titan Technology's stock price decreased by 2.15%, trading at 24.13 yuan per share, with a total market capitalization of 3.968 billion yuan [1] - Year-to-date, the stock price has increased by 32.80%, with a slight increase of 0.54% over the last five trading days, but a decline of 0.33% over the last 20 days and 13.33% over the last 60 days [1] - The number of shareholders as of September 30 was 9,293, an increase of 20.41% from the previous period, while the average circulating shares per person decreased by 16.95% to 17,694 shares [2] Business Segmentation - The main business revenue composition includes: research reagents (42.70%), research instruments and consumables (28.42%), specialty chemicals (26.48%), laboratory construction and research information technology (2.37%), and others (0.02%) [1] - Titan Technology is classified under the Shenwan industry as basic chemicals - chemical products - other chemical products, and is associated with concepts such as share buybacks, margin financing, electronic chemicals, pension concepts, and scientific instruments [1]

Group 1 - The company will hold an investor briefing on November 18, 2025, from 13:00 to 14:00, to discuss its Q3 2025 performance and financial indicators [2][5]. - Investors can participate in the briefing via the Shanghai Stock Exchange Roadshow Center's website [4][5]. - Questions from investors can be submitted between November 11 and November 17, 2025, through the designated online platform or via email [2][6]. Group 2 - The briefing will be conducted in an interactive online format, allowing for real-time communication between the company and investors [3][5]. - Key personnel attending the briefing include the Chairman, General Manager, Board Secretary, and Chief Financial Officer [5]. - After the briefing, investors can access the main content and details of the event on the Shanghai Stock Exchange Roadshow Center's website [6].

Core Insights - Titan Technology's stock price increased by 2.15% on November 11, reaching 24.75 CNY per share, with a market capitalization of 4.07 billion CNY [1] - The company has seen a year-to-date stock price increase of 36.21%, with a recent 5-day increase of 2.87% and a 20-day increase of 3.08%, although it has declined by 12.36% over the past 60 days [1] - For the period from January to September 2025, Titan Technology reported a revenue of 1.848 billion CNY, a year-on-year decrease of 13.06%, while net profit attributable to shareholders increased by 15.04% to 11.17 million CNY [2] Financial Performance - As of September 30, the number of shareholders for Titan Technology increased by 20.41% to 9,293, while the average number of tradable shares per shareholder decreased by 16.95% to 17,694 shares [2] - Cumulatively, Titan Technology has distributed 86.62 million CNY in dividends since its A-share listing, with 40.11 million CNY distributed over the past three years [3] Business Overview - Titan Technology, established on October 18, 2007, and listed on October 30, 2020, is based in Shanghai and specializes in providing integrated technical solutions for scientific services, including research reagents, laboratory instruments, and specialized chemicals [1] - The company's revenue composition includes 42.70% from research reagents, 28.42% from scientific instruments and consumables, 26.48% from specialized chemicals, and 2.37% from laboratory construction and scientific information services [1]

证券代码：688133 证券简称：泰坦科技 公告编号：2025-043 上海泰坦科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 三、 参加人员 董事长：谢应波先生 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 11 日 （星期二） 至 11 月 17 日 （星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 contact@titansci.com 进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 上海泰坦科技股份有限公司（以下简称"公司"）已于 2025 年 10 月 31 日发 布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 2025 年 11 月 18 日 （星期二） 13:00-14:00 举行 2025 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2025 ...

Core Points - The board of directors and senior management of Titan Technology Company guarantee the authenticity, accuracy, and completeness of the quarterly report, and they bear legal responsibility for any false records, misleading statements, or significant omissions [2][3][5] Financial Data Summary - The financial statements for the third quarter are unaudited, covering the period from the beginning to the end of the quarter [3][5] - The report includes major accounting data and financial indicators, with specific attention to non-recurring gains and losses [3][4] - The company has not reported any significant changes in major accounting data or financial indicators during the reporting period [4][5] Shareholder Information - There are no changes reported in the number of shareholders or the shareholding structure of the top ten shareholders compared to the previous period [4][5] Other Important Information - The company has not identified any additional important information regarding its operational performance during the reporting period that needs to be highlighted to investors [5][6]